On this episode of Oncology Unscripted, patient advocates Julie Johnson and Katie Coleman and radiation oncologist Dr. Matt Spraker continue The Insider's Guide to Radiation Therapy!
Here are the figures/graphics we referenced during the show:
- The first figure we discussed, demonstrating the Bragg Peak and the difference between proton and photon (x-ray) beams.
- The second figure we discussed, comparing 3D photon (x-ray) radiation, intensity modulated radiotherapy with photons (x-ray), passive scatter and intensity modulated proton therapy.
Here are some other things we discussed during the show:
- Relative biological effectiveness in radiobiology
- A video about "IMRT for proton therapy", or pencil beam scanning proton therapy, from manufacturer IBA.
- Brada review of proton evidence, questioning whether the US should open so many proton centers so quickly.
- Goitein and Cox response to Brada, arguing that the benefit of proton therapy is self-evident.
- Glatstein, Glick, Kaiser, and Hahn, arguing that trials are needed to prove the benefit of proton therapy.
- Liao et al., randomized phase II trial of proton versus photon (x-ray) radiotherapy for locally advanced non-small cell lung cancer.
- RTOG 1308, randomized phase III trial of proton versus photon (x-ray) radiotherapy for locally advanced non-small cell lung cancer. Now filled, awaiting results!
- Lin et al., randomized phase IIB trial of proton versus photon (x-ray) radiotherapy for locally advanced esophageal cancer.
- NRG GI-006, randomized phase III trial of proton versus photon (x-ray) radiotherapy for locally advanced esophageal cancer, enrolling now!
Oncology Unscripted is a Photon Media production. Intro and Outro music by Emmy-award winning artist Lucas Cantor Santiago.
Additional content from Katie Coleman can be found at her website, https://www.katiekickscancer.com/.
This show and our opinions are meant for general informational purposes and are not medical advice. We encourage you to reach out to your doctors to discuss your individual case.